Glucose Infusion Rate (GIR) Calculator

How to Use This Calculator

1. Enter dextrose concentration (%), infusion rate (mL/hr), and patient weight (kg).
2. GIR in mg/kg/min and clinical status display instantly.
3. Use Target Rate Finder tab to calculate the rate needed for a desired GIR.
4. Professional tier adds blood glucose context and bolus guidance.

Formula

Example

Frequently Asked Questions

• What is glucose infusion rate (GIR) and why does it matter in neonates? ▼
  Glucose infusion rate (GIR) is the amount of glucose delivered intravenously per unit time per unit body weight, expressed in milligrams of glucose per kilogram of body weight per minute (mg/kg/min). It is the primary parameter used to manage intravenous glucose therapy in neonates, particularly in the neonatal intensive care unit. Neonates — especially preterm infants, small-for-gestational-age infants, and infants of diabetic mothers — are at high risk for hypoglycemia because they have limited glycogen stores, immature gluconeogenesis, high glucose utilization rates relative to body size, and disrupted glucose-insulin regulation following birth. The brain is highly vulnerable to hypoglycemia-induced injury during the newborn period, making timely and adequate glucose support critical. GIR allows clinicians to precisely calculate and adjust the glucose delivery from any dextrose-containing intravenous fluid, regardless of the concentration used. The neonatal brain requires a continuous glucose supply of approximately 4-6 mg/kg/min under basal conditions. Hepatic glucose production in term neonates is approximately 4-6 mg/kg/min. The standard initial GIR target for term neonates is 4-8 mg/kg/min, and for preterm infants it is typically 6-8 mg/kg/min, with upward titration to 10-12 mg/kg/min permitted for hyperinsulinemic hypoglycemia. Understanding GIR prevents both undertreating hypoglycemia (with inadequate glucose delivery) and overtreating (with hyperglycemia from excessive GIR).
• What is the GIR formula and how is it derived? ▼
  The GIR formula is: GIR (mg/kg/min) = (Dextrose concentration % × Infusion rate mL/hr) / (6 × Weight kg). This formula is derived from unit conversions. Dextrose concentration expressed as a percentage means grams of glucose per 100 mL of solution — so a 10% dextrose solution contains 10 g per 100 mL or 100 mg/mL. Infusion rate in mL/hr must be converted to mL/min by dividing by 60. Therefore: GIR = (concentration mg/mL × rate mL/hr / 60 min/hr) / weight kg = (concentration × rate) / (60 × weight). Since concentration % × 10 = mg/mL, and 10/60 simplifies to 1/6: GIR = (Dextrose% × rate) / (6 × weight). As an example, a 3 kg neonate receiving D10W at 7.5 mL/hr: GIR = (10 × 7.5) / (6 × 3) = 75 / 18 = 4.2 mg/kg/min — within the target range. If using SI units (mmol/kg/min), divide by 18 to convert from mg. Clinicians should always verify the calculated GIR against the clinical target before administering, particularly when changing dextrose concentrations or when transitioning between peripheral (maximum D12.5W) and central (D>12.5W) access.
• What are the target GIR ranges for neonates and how are they titrated? ▼
  GIR targets vary by gestational age and clinical condition. For term neonates (gestation ≥37 weeks), the initial GIR target is 4-6 mg/kg/min, reflecting the hepatic glucose production rate of a healthy term newborn. A GIR of 6-8 mg/kg/min is acceptable and often used to correct hypoglycemia or when enteral intake is limited. For preterm neonates (gestation <37 weeks), initial GIR is typically 6-8 mg/kg/min because of higher glucose utilization relative to glycogen stores and immature endogenous glucose production. A GIR above 8 mg/kg/min in the absence of documented hyperinsulinism should prompt evaluation for an underlying cause. GIR of 10-12 mg/kg/min is used for hyperinsulinemic hypoglycemia (e.g., persistent hyperinsulinism, infant of diabetic mother with prolonged hypoglycemia). GIR exceeding 12.5 mg/kg/min requires a central venous catheter due to the high osmolarity of the dextrose solution needed. Titration is guided by point-of-care blood glucose checks, targeting euglycemia of 47-150 mg/dL in neonates per AAP and PES guidelines. GIR should be adjusted in increments of 1-2 mg/kg/min, and blood glucose should be rechecked 30-60 minutes after each change. Abrupt discontinuation of high GIR must be avoided to prevent rebound hypoglycemia.
• What are the maximum safe dextrose concentrations for peripheral vs central IV access? ▼
  Osmolarity limits the safe concentration of dextrose solutions that can be infused through peripheral veins. High-concentration dextrose solutions are hyperosmolar and cause phlebitis, thrombosis, and tissue necrosis if they extravasate from a peripheral IV. The generally accepted maximum dextrose concentration for peripheral IV administration in neonates is 12.5% (D12.5W), which has an osmolarity of approximately 630 mOsm/L. Some institutions use D10W as their maximum peripheral concentration to reduce risk. Central venous access (umbilical venous catheter, PICC line, or surgically placed central line) is required for dextrose concentrations greater than 12.5%. Central lines can safely deliver D15W, D20W, D25W, or higher concentrations used in total parenteral nutrition. In clinical practice, when a neonate requires a GIR greater than what D12.5W can deliver at acceptable fluid volumes, central access is indicated. For a 1 kg preterm infant, D12.5W at 100 mL/kg/day (4.2 mL/hr) delivers a GIR of only 5.2 mg/kg/min — demonstrating why very preterm, very low birth weight infants frequently require central access and higher dextrose concentrations. Peripheral extravasation of hypertonic dextrose is a significant cause of neonatal skin injury and must be monitored through regular IV site inspection.
• How does GIR relate to neonatal hypoglycemia treatment protocols? ▼
  Neonatal hypoglycemia management protocols increasingly incorporate GIR as a standard parameter alongside blood glucose thresholds. The Pediatric Endocrine Society (PES) 2015 clinical practice guideline and the American Academy of Pediatrics (AAP) define neonatal hypoglycemia as plasma glucose below 47 mg/dL in the first 48 hours, with treatment thresholds varying by age and clinical context. The standard treatment for symptomatic hypoglycemia or glucose below 40 mg/dL is an IV glucose bolus of 200 mg/kg (2 mL/kg of D10W), followed by a maintenance infusion at GIR 6-8 mg/kg/min. If hypoglycemia persists despite GIR ≥8-10 mg/kg/min, hyperinsulinism must be suspected and diagnostic workup (insulin, C-peptide, cortisol, growth hormone during hypoglycemia) initiated. Diazoxide is the first-line treatment for congenital hyperinsulinism, with octreotide as an alternative. The GIR calculation is critical here: a GIR of 10 mg/kg/min or greater is the primary diagnostic criterion for hyperinsulinism in the neonatal period, as endogenous glucose production can supply only 4-6 mg/kg/min. If glucose requirements exceed this — with persistent hypoglycemia — exogenous insulin suppression of gluconeogenesis must be suspected. GIR tracking over time (requiring GIR trend documentation) helps identify whether hypoglycemia is worsening, improving, or transitioning to the hyperinsulinemic phenotype.

Related Calculators